Groundbreaking Gene Therapy Solves Lily's Sickle Cell Disease
After years of care at CHOP, including groundbreaking gene therapy delivered as part of a clinical trial, 11-year-old Lily continues to not only grow and gain but thrive.
After years of care at CHOP, including groundbreaking gene therapy delivered as part of a clinical trial, 11-year-old Lily continues to not only grow and gain but thrive.
An FDA-approved gene therapy eliminates acute pain episodes for people with sickle cell disease and transforms their life expectancy.
For years, sickle cell disease caused frequent pain crises and hospitalizations for Asher. A curative therapy has eliminated those harrowing experiences.
Sickle cell disease brings constant fear of life-threatening complications. A successful bone marrow transplant ended those fears for Dallas and her family.